Dr. Hari Goyal

Dr. Hari Goyal is a renowned and highly respected Medical Oncologist who has made significant contributions to the field of cancer care in India. With over 25 years of experience, he is recognized for his expertise in targeted therapy, chemotherapy, and immunotherapy, and is widely regarded as one of the best oncologists in India for targeted treatment approaches. He started his medical journey at the prestigious Tata Memorial Centre, one of India’s leading cancer institutes, and subsequently completed his DM in Oncology from AIIMS, New Delhi, the country’s premier medical institution. Throughout his career, Dr. Goyal has been deeply involved in clinical research and drug development, including the creation of medications that help manage chemotherapy-related side effects—one of his landmark achievements. Dr. Goyal has treated patients from over 25–28 countries, making him a sought-after oncologist for complex and advanced cancer cases. His specialized approach to immunotherapy BITe and targeted therapy has helped significantly improve survival rates and quality of life for patients with late-stage and metastatic cancers, including cancers that have spread to the brain, lungs, and other solid organs. He continues to be at the forefront of oncology practice in India, leading innovative treatment strategies for Stage 4 cancers and metastatic disease. His dedication to patient-centered care, research involvement, and consistent innovation has firmly established him as a leading figure in medical oncology.